Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05171088 · ClinicalTrials.gov registry record
Colorectal Resection in Emergency General Surgery
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 16
- Enrollment target
NCT05171088: Completed study, sponsored by Methodist Health System.
NCT05171088 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05171088 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Primary anastomosis is associated with higher rates of perioperative morbidity/mortality and that fecal diversion improves overall mortality, decreases length of stay, and lowers rates of surgical complications requiring unplanned operative intervention.
Primary Outcome
Perioperative mortality and need for unplanned procedural intervention (intervention by a surgeon, radiologist, or interventional radiologist).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2021-03-08 |
What the finished NCT05171088 record still lists
NCT05171088 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05171088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05171088 about?
NCT05171088 is a clinical study titled "Colorectal Resection in Emergency General Surgery". Primary anastomosis is associated with higher rates of perioperative morbidity/mortality and that fecal diversion improves overall mortality, decreases length of stay, and lowers rates of surgical complications requiring unplanned operative intervention.
What is the current status of trial NCT05171088?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2018-04-04. Estimated completion is 2021-03-08.
Who is sponsoring clinical trial NCT05171088?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI